Piper Sandler Lowers AlloVir (NASDAQ:ALVR) to Neutral

Piper Sandler lowered shares of AlloVir (NASDAQ:ALVR – Free Report) from an overweight rating to a neutral rating in a report issued on Friday, MarketBeat reports. Separately, JPMorgan Chase & Co. lowered AlloVir from an overweight rating to an underweight rating in a report on Friday. One investment analyst has rated the stock with a […]

Related Keywords

Piper Sandler ,Allovir Company Profile ,Jpmorgan Chase Co ,Vanguard Group Inc ,Blackrock Inc ,Artal Group ,Allovir Inc ,Free Report ,Get Free Report ,Vanguard Group ,Allovir Daily ,Allovir ,Nasdaq Alvr ,Alvr ,Medical ,Downgrade ,